American Assets Inc. Boosts Position in Align Technology, Inc. $ALGN

American Assets Inc. raised its stake in Align Technology, Inc. (NASDAQ:ALGN) by 66.7% during the second quarter, Holdings Channel.com reports. The institutional investor owned 5,000 shares of the medical equipment provider’s stock after purchasing an additional 2,000 shares during the quarter. Align Technology accounts for about 0.3% of American Assets Inc.’s portfolio, making the stock its 10th largest position. American Assets Inc.’s holdings in Align Technology were worth $905,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its position in Align Technology by 2,900.0% during the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 174 shares during the period. SVB Wealth LLC bought a new position in Align Technology in the first quarter worth about $36,000. Farther Finance Advisors LLC boosted its position in shares of Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 92 shares in the last quarter. Mather Group LLC. grew its stake in Align Technology by 375.0% in the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 345 shares during the period. Finally, Assetmark Inc. lifted its position in Align Technology by 327.6% during the second quarter. Assetmark Inc. now owns 449 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 344 shares during the period. Institutional investors own 88.43% of the company’s stock.

Wall Street Analysts Forecast Growth

ALGN has been the topic of a number of recent research reports. HSBC upped their target price on shares of Align Technology from $140.00 to $150.00 in a research report on Friday. Zacks Research raised shares of Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 30th. Morgan Stanley boosted their price target on Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research report on Thursday. Evercore ISI upped their price target on Align Technology from $160.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, Mizuho dropped their target price on Align Technology from $210.00 to $170.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Align Technology has a consensus rating of “Hold” and a consensus price target of $175.45.

Align Technology Trading Down 0.4%

Align Technology stock opened at $137.88 on Monday. The firm has a market cap of $9.99 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 1.49 and a beta of 1.70. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $246.19. The stock has a fifty day simple moving average of $133.23 and a two-hundred day simple moving average of $161.75.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, topping the consensus estimate of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.Align Technology’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same period last year, the company earned $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. On average, equities research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology announced that its Board of Directors has initiated a stock buyback program on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.